États-Unis · Places boursières & cours · Nasdaq

AstraZeneca Projects $80 Bln In Total Revenue By 2030, Sustained Growth Beyond

Publié par Nasdaq · États-Unis il y a 3 h

(RTTNews) - British drug major AstraZeneca Plc (AZN, AZN.L) announced that it aims for $80 billion in total revenue by 2030, and sustained growth beyond the year.

Lire l'article complet sur Nasdaq Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.nasdaq.com)

AstraZeneca Projects $80 Bln In Total Revenue By 2030, Sustained Growth Beyond

À lire aussi

Trump Moves to Ease Methane Regulations for U.S. Oil Producers

Brazilian Stocks Sink After Surprising Presidential Election Result

Latest Monero (XMR) Price Analysis

Tech Sell-Off Leads to Uptick in Defensive Stocks

Introducing new self-learning context enrichment in Knowledge Catalog

AstraZeneca Projects $80 Bln In Total Revenue By 2030, Sustained Growth Beyond

Partager

À lire aussi

Trump Moves to Ease Methane Regulations for U.S. Oil Producers

Brazilian Stocks Sink After Surprising Presidential Election Result

Latest Monero (XMR) Price Analysis

Tech Sell-Off Leads to Uptick in Defensive Stocks

Introducing new self-learning context enrichment in Knowledge Catalog